Article Sidebar
Published:
Oct 12, 2005Keywords:
Ciprofloxacin Reversed-phase HPLC Pharmacokinetics Ofloxacin
Article Details
Issue
Section
Articles
Copyright of articles published shall reside exclusively with the Faculty of Pharmaceutical Sciences, University of Jos.
DECLARATION & COPYRIGHT TRANSFER
I/We the undersigned author(s) of article entitled
…………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………
Declare as follows:
- The manuscript submitted to Journal of Pharmacy & Bioresources is original and has not been and will be published, whole or in part, in print or electronic format, in any other journal. It is also not being currently considered for publication in any journal.
- The submitted manuscript is a joint decision of all the coauthors.
- Each author has participated sufficiently in the work to warrant his or her inclusion in the list of authors. To this end, each author takes responsibility for appropriate portions of the manuscript.
- Authors have obtained necessary approval to carry out the experiments on animals and human subjects. Approval certificates will be furnished, if required by publishers or editors of the journal.
- Authors do not have any conflict of interest (financial or otherwise) other than those declared.
- If the manuscript is accepted for publication, the authors transfer and assign copyright of the article referenced above to Journal of Pharmacy and Bioresources.
Name & Signature of authors
1. 2.
- 4.
- 6.
- 8.
Corresponding authors name address, affiliation and email:
Main Article Content
High performance liquid chromatographic determination of ciprofloxacin in human plasma and urine and its application to pharmacokinetic studies
Abstract
A simple, highly sensitive and selective reversed-phase HPLC assay with UV detection for the determination of ciprofloxacin in human plasma and urine was developed and validated. The drug and internal standard, ofloxacin, were extracted from plasma or urine with isopropanol:methylene chloride (1:9, v/v) and back extracted with orthophosphoric acid. Separation was achieved on a C18 reversed-phase column with a mobile phase of acetonitrile:methanol:0.1M sodium dihydrogen orthophosphate:triethylamine:glacial acetic acid (8:10:83:1:2, v/v) and UV detection at 278 nm. The chromatograms were free from interference at the retention times of ciprofloxacin and the internal standard while both compounds eluted as completely resolved peaks. The calibration curves were linear (r2 %ge; 0.996) over concentration ranges of 0.01 to 3.0 µg/ml in plasma and 0.05 to 5.0 µg/ml in urine. The method was reproducible with coefficients of variation <6% for both inter-and intra-day assays while the limits of quantitation were 10 ng/ml in plasma and 50 ng/ml in urine. Recoveries for ciprofloxacin and internal standard were >98% in both plasma and urine. The method was successfully applied to estimate the pharmacokinetics of ciprofloxacin after oral administration of a 500 mg dose of ciprofloxacin tablets to 12 healthy volunteers.
Key words: Ciprofloxacin; Reversed-phase HPLC; Pharmacokinetics; Ofloxacin
Journal of Pharmacy and Bioresources Vol. 2 (1) 2005: 55-64
Key words: Ciprofloxacin; Reversed-phase HPLC; Pharmacokinetics; Ofloxacin
Journal of Pharmacy and Bioresources Vol. 2 (1) 2005: 55-64
